CoChat

Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network

Open access
Bussy, Aurélie, Snider, B. Joy, Coble, Dean, Xiong, Chengjie, Fagan, Anne M., Cruchaga, Carlos, Benzinger, Tammie L.S., Gordon, Brian A., Hassenstab, Jason, Bateman, Randall J., Morris, John C. · 2019 · Neurobiology of Aging
Cited by 54

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

The apolipoprotein E ε4 allele (APOE4) is the major genetic risk factor for sporadic Alzheimer Disease (AD). APOE4 may have effects on cognition and brain atrophy years before the onset of symptomatic AD. We analyzed the effects of APOE4 in a unique cohort of young adults who had undergone comprehensive assessments as part of the Dominantly Inherited Alzheimer Network (DIAN), an international longitudinal study of individuals from families with Autosomal Dominant AD. We analyzed the effect of an APOE4 allele on cognitive measures, volumetric MRI, amyloid deposition, glucose metabolism and on cerebrospinal fluid levels of AD biomarkers in 162 participants that did not carry the mutant gene (non-carriers). APOE4+ and APOE4− mutation non-carriers had similar performance on cognitive measures. Amyloid deposition began at an earlier age in APOE4+ participants, while hippocampal volume was similar between the groups. These preliminary findings are consistent with growing evidence that the APOE4 allele may exert effects in mid-life years before symptom onset, promoting amyloid deposition before altering cognitive performance or brain structure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2018.10.011

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 54

Metadata

Authors
Bussy, A., Snider, B. J., Coble, D., Xiong, C., Fagan, A. M., Cruchaga, C., Benzinger, T. L. S., Gordon, B. A., Hassenstab, J., Bateman, R. J., & Morris, J. C.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2019-03
Volume
75
Pages
42-50
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2896756073
Cited by
54
References
25
FWCI
5.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2018.10.011
The paper
Bussy, A., Snider, B. J., Coble, D., Xiong, C., Fagan, A. M., Cruchaga, C., Benzinger, T. L. S., Gordon, B. A., Hassenstab, J., Bateman, R. J., & Morris, J. C. (2019). Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2018.10.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.